Loading…
VTRS · NASDAQ · Pharmaceuticals
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund holdings · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in VTRS for Q2 2026Source5%+ stake · Stake as of Jun 30, 2026 · Filed Aug 6, 2026
FMR LLC now owns 8.3% of VTRS as a passive investorSourceInsider trade · Traded Jun 25, 2026 · Filed Jun 26, 2026
Officer sold ~$810K of VTRS shares in the open marketSourceInsider trade · Traded Mar 23, 2026 · Filed Mar 24, 2026
Officer sold ~$284K of VTRS shares in the open marketSourceInsider trade · Traded Aug 27, 2025 · Filed Mar 10, 2026
Director purchased ~$3K of VTRS shares in the open marketSourceInsider trade · Traded Nov 3, 2025 · Filed Mar 10, 2026
Director purchased ~$2.2K of VTRS shares in the open marketSourceCongress trade · Transaction Nov 18, 2025 · Disclosed Dec 15, 2025
Disclosed purchase of VTRS — reported range $1,001 - $15,000SourceCongress trade · Transaction Apr 8, 2025 · Disclosed May 8, 2025
Disclosed sale of VTRS — reported range $1,001 - $15,000SourceCongress trade · Transaction Mar 31, 2025 · Disclosed Apr 7, 2025
Disclosed partial sale of VTRS — reported range $1,001 - $15,000SourceCongress trade · Transaction Feb 25, 2025 · Disclosed Mar 27, 2025
Disclosed purchase of VTRS — reported range $1,001 - $15,000Source